Your session is about to expire
← Back to Search
Near-Infrared Transcranial Photobiomodulation for Down Syndrome (TransPhoM-DS Trial)
TransPhoM-DS Trial Summary
This trial will help researchers understand if a transcranial photobiomodulation (tPBM) can improve neural oscillations for people with Down syndrome.
TransPhoM-DS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTransPhoM-DS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TransPhoM-DS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment still open for this experiment?
"Confirmed, the trial is actively recruiting. The clinical study was originally listed on October 19th 2021 and has been modified November 8th 2021 according to data provided by clinicaltrials.gov."
How many participants are being assessed in this trial?
"Affirmative. The details hosted on clinicaltrials.gov indicates that this research is actively trying to find participants, which was first posted on October 19th 2021 and updated recently on November 8th 2021. For the trial, 23 subjects are being recruited from one site."
Is the cut-off age for this trial beyond 45 years?
"As outlined in the eligibility requirements, only those aged 18 to 30 are allowed to join this clinical trial."
Is it feasible for me to become a participant in this clinical research?
"This clinical trial is suitable for individuals who are aged between 18 and 30, have been diagnosed with Down's Syndrome, and seek to be one of the 23 enrolled patients."
Share this study with friends
Copy Link
Messenger